Abstract:Chinese hamster ovary (CHO) cells have become the mainstream in expression systems for producing therapeutic antibodies.The cultivation of CHO cells and expression of antibody are extremely related to culturing environment.We previously generated a fusion antibody named JZB01 targeting vascular endothelial growth factor receptor 2 (VEGFR2) and natural killer cells with significant anti-tumor activity but limited production.In this study,we aim to develop a robust method for fed-batch fermentation using design of experiments (DOE) with Minitabl 6.0,and evaluate the influence of commercial media,supplements and culture conditions on cell viability and antibody production.To improve the yield of fusion protein and establish a strategy for further study,the optimization of the production was undertook with orthogonal experimental analysis for four factors and the level was assessed by the response.Furthermore,in order to sustain the stability and uniformity of fusion protein for further research and diagnosis,the bioprocess was scaled up to a 3-L bio-reactor under the conditions of commercial medium CDM4PerMAb,supplemented with Boost2 + Boost5,12％ (V/V) volume,1 × 106 cells/mL of initial density and 2 days of feeding.The final yield was 54.45 mg/L and Western blot was adopted to identificated the affinity of fusion protein preliminarily,which was characterized as a homodimer with binding ability to each receptor.By the investigation for anti-angiogenesis function of JZB01 on HUVEC cells and anti-tumor function on MDA-MB-231 cells and K562 cells,the MrTT assay confirmed that the fusion protein had anti-angiogenic effect and enhanced anti-tumor activities.Thus,by establishing a platform to obtain fusion protein with high molecular weight in CHO cells system along with moderate costs,this study provides a robust methodology for producing therapeutic antibodies at laboratory level.And more trials will be taken to enlarge the application to industrial scale which could be applied in vitro and vivo preclinical tests.

[Development of a Fed-Batch Process for TNFR-fc Producing GS-CHO Cells].

Rational development of a serum-free medium and fed-batch process for a GS-CHO cell line expressing recombinant antibody

A High-Yielding, Generic Fed-Batch Process for Recombinant Antibody Production of GS-Engineered Cell Lines

Increasing the Productivity of TNFR-Fc in GS-CHO Cells at Reduced Culture Temperatures

Continuous Feeding Reduces the Generation of Metabolic Byproducts and Increases Antibodies Expression in Chinese Hamster Ovary-K1 Cells

Development of A Fed-Batch Cultivation for Antibody-Producing Cells Based on Combined Feeding Strategy of Glucose and Galactose

Efficient Production of Stnfrii-Gad Fusion Protein in Large Quantity by Use of the Modified CHO-S Cell Expression System

Application of Improved Top-Down Approach in Maximizing Cho Cell Mass and Productivity in Fed-Batch Culture

Development of Production Procedure and Quality Control Method for Recombinant CHO Cells with Human Type Ⅱ Tumor Necrosis Factor Receptor-Fc Fusion Gene

Fed-Batch Culture Optimization of A Growth-Associated Hybridoma Cell Line in Chemically Defined Protein-Free Media

Fermentation Optimization of an Anti-VEGFR2-MICA Fusion Protein Adopting Design of Experiments (DOE)

Impact of fed-batch process intensification on the productivity and product quality of two CHO cell lines expressing unique novel molecular format proteins

High-Level Production of scFv-Fc Antibody Using an Artificial Promoter System with Transcriptional Positive Feedback Loop of Transactivator in CHO Cells

Progress in fed-batch culture for recombinant protein production in CHO cells

Fed-Batch Culture Of Hybridoma Cells In Serum-Free Medium Using An Optimized Feeding Strategy

Enhancement of anti-TNFα monoclonal antibody production in CHO cells through the use of UCOE and DHFR elements in vector construction and the optimization of cell culture media

Bioprocess Development of a Stable FUT8−/−-CHO Cell Line to Produce Defucosylated Anti-Her2 Antibody

CHO cell productivity improvement by genome-scale modeling and pathway analysis: Application to feed supplements

Deciphering Metabolic Pathways in High-Seeding-Density Fed-Batch Processes for Monoclonal Antibody Production: A Computational Modeling Perspective

High Through-Put Screening and Optimization of Serum-free Media Development for CHO Cells Using Simplex Lattice and Elements Dialogue Design Methods

Scale-up of Procedure for Culture of Recombinant CHO Cells Expressing Tumor Necrosis Factor Receptor-Fc in Rotary Shaker and Determination of Biological Activity of Expressed Product